Early Look

Thursday, November 19, 2026

Futures

Up/Down

%

Last

Dow

359.00

0.71%

50,632

S&P 500

94.25

1.28%

7,434

Nasdaq

627.50

2.31%

27,814

 

 

U.S. futures are looking much better than they have the last few days, with Nasdaq futures surging more than 2% or 600 points overnight and the S&P 500 index is looking to snap its 5-day losing streak after Anthropic priced its IPO above the marketed range, bolstering expectations for a strong debut and reviving sentiment around beaten-down AI stocks. Anthropic (ANT) priced its upsized IPO at $83 per share, above its $70-$78 range, raising $81B in the largest listing on record that valued the AI lab at about $1.5 trillion. The US dollar index (DXY) is slipping following a seven-session winning streak but remained underpinned by hawkish remarks from a Federal Reserve official that reinforced the case for further rate hikes. Fed ‌Governor Christopher Waller called for a more aggressive response to inflation, while minutes of the central bank's October 27 ‌to 28 meeting showed policymakers increasingly concerned that additional tightening might be needed. Despite the easing in the dollar, precious metals remain at more than 1 year lows. US stocks ended mixed on Wednesday, with the Nasdaq advancing while the Dow slumped just over 1% in the wake of earnings from Nvidia, and more hawkish commentary from the Federal Reserve. In Asian markets overnight, The Nikkei Index gained 419 points to 59,444, the Shanghai Index fell -10 points to 3,577, and the Hang Seng Index dropped -453 points to 22,841. In Europe, the German DAX is up 90 points to 25,827, while the FTSE 100 is down -28 points to 10,522. Also on the calendar today, consumer bellwether Walmart (WMT) reports earnings before the bell, and other retailers, such as The Gap (GAP) and Bath & Body Works (BBWI), will also report results. Initial jobless claims and manufacturing activity data will provide updates on the US's economic health.

 

Market Closing Prices Yesterday

  • The S&P 500 Index slipped -16.90 points, or 0.23%, to 7,323.63
  • The Dow Jones Industrial Average fell -561.25 points, or 1.11%, to 50,198.17
  • The Nasdaq Composite gained 101.50 points, or 0.42%, to 24,429.89
  • The Russell 2000 Index advanced 12.44 points, or 0.46% to 2,714.31

Economic Calendar for Today

  • 8:30 AM ET                   Weekly Jobless Claims…est. 197K
  • 8:30 AM ET                   Continuing Claims…est. 1.71M
  • 8:30 AM ET                   Philly Fed Business Index for November…est. 20.0 (prior 20.9)
  • 10:00 AM ET                 Leading Index M/M for October…est. 0.0%
  • 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data
  • 11:00 AM ET                 Kansas City Fed Manufacturing for November

Earnings Calendar:

  • Earnings Before the Open: ARBE BABA BBWI DAO EVGN FUTU LQDT MANU MMS NTES RERE ROAD TEN VVV WMG WMT YMM
  • Earnings After the Close: BULL CLIR EARN ESE ESTC GAP GLOB INTU KEYS MATW NGVC POST ROST

Other Key Events:

  • Deutsche Bank Gaming, Lodging, Leisure One on One Conference 11/19-11/20, in Miami, FL
  • Supercomputing 2026, 11/15-11/20, in New Orleans

 

 

Macro

Up/Down

Last

Nymex

-0.46

82.80

Brent

-0.47

91.48

Gold

-13.70

3,728.20

EUR/USD

0.0024

1.0998

JPY/USD

0.63

159.91

10-Year Note

+0.01

5.08%

 

World News

  • President Trump is currently in Shenzhen, China, for the APEC Summit, where he met with world leaders, including Canadian Prime Minister Mark Carney, Chinese President Xi Jinping, and Russian President Putin.
  • The bull-bear spread in the American Association of Individual Investors (AAII) weekly survey was -8.9% vs -20.6% last week. Bulls rose to 33.3% to from 30.8%, Neutrals rose to 24.4% from 17.8%, Bears fell to 42.2% from 51.4%.

Sector News Breakdown

Consumer

  • Ali Baba (BABA) Quarterly revenue reaches 271.52 billion yuan, topping estimates as demand for its AI cloud services surged, while investment gains helped more than triple reported profit; Excluding investment gains and other items, non-GAAP net income leapt 92% to 19.9 billion yuan
  • Red Robin Gourmet Burgers (RRGB) Q3 adj EPS loss (-$0.54) vs. est. loss (-$0.34); Q3 revs fell -12% y/y to  $232.1M vs. est. $253.6M; Q3 FY26 net loss widened 15% y/y to -$21.19M; chain refranchised 108 restaurants during the quarter for approximately $89.4M in cash; guides Q4 adj Ebitda about $6M.
  • Universal Technical (UTI) Q3 EPS $0.32 and revs $235.9M vs. est. $235.04M; said grew new student starts, average full-time active students and revenue by 7% y/y each, with revenue reaching $897M; guides Fy rev outlook to $925M-$945M vs. est. $966.6M; guides FY27 adj EBITDA guidance $100M-$106M; growth investment expenses will reach approximately $115M, up $50M, as spending precedes expansion.

Energy, Industrials and Materials

  • Equinor (EQNR) said a cyberattack against it is still ongoing, but production is running as normal; said there are still no signs data has leaked and it does not appear to be a targeted attack against the company.
  • Helmerich & Payne (HP) Q4 adj EPS $0.36 vs. est. $0.27; Q4 revs $1.1B vs. est. $1.073B; said expect numerous growth opportunities across key markets to drive stronger overall direct margins compared to FY26; guides FY capex view $320M-$360M; expect to operate average 19 rigs through Q1, with potential for further activity reductions over course of year.
  • Modexus Solutions (MOD) said it expects 60–80% revenue growth in data Centers and 7–10% in commercial HVAC fy2027–fy2029; expects fy2029 adj EBITDA margin of 22–24% in data Centers and 20–22% in commercial HVAC; targets 40–55% three-year revenue CAGR and 19–21% adj EBITDA margin in fy2029.
  • Pure Cycle (PCYO) Q4 EPS $0.23 vs. $0.25 Y/Y, revenue $13.2Mm, up 18% Y/Y, and EBITDA $8.45Mm, down 5% Y/Y; FY26 revenue rose 37% to a record $35.7Mm as lot sales rose 45%, Water and wastewater revenue rose 30%, and rental revenue rose 73%, while FY26 EBITDA rose 9% to $22.0M.
  • Star Bulk Carriers (SBLK) Q3 Adjusted EPS $1.28 vs. est. $1.19 (beat), voyage revenue $366.916Mm vs. est. $312.29Mm (beat), and adjusted EBITDA $194.453Mm vs. est. $196.2Mm (miss); declares a $1.00/share quarterly dividend, its highest since Q3 FY22.
  • Woodward (WWD) Q4 Adjusted EPS $2.83, up 35% Y/Y, vs. est. $2.51 (beat); sales $1.200B vs. est. $1.141B (beat); adjusted EBIT $236Mm; sees FY27 adjusted EPS $10.20-$10.70 vs est $10.75 (below), sales growth 6%-10% vs est +9.05% (in-line) and FCF $400Mm-$450Mm, with slower margin expansion.

Financials

  • StoneX Group (SNEX) Q4 EPS $0.66 vs. est $0.88 (miss); net operating revenue $655.2Mm, pretax profit $119.6Mm and ROE 11.6%.

Healthcare

  • Biohaven (BHVN) price target raised to $35 from $14 at JPMorgan and stays Overweight rated citing the FDA accepting for review the new drug application resubmission for Vyglxia in spinocerebellar ataxia. JPMorgan believes there is the potential for upside from current share levels and remains positive.
  • Elanco (ELAN) announces inaugural $600M share repurchase authorization.
  • Novartis (NVS) set a target of annual sales growth of 5% through 2031, which is lower than a 5% to 6% annual sales growth range it set last year for 2025-2030. By 2031, breast cancer drug Kisqali and Cosentyx for autoimmune diseases, two of Novartis' best-selling medicines, will face competition from cheaper rivals.

Technology, Media & Telecom

  • Anthropic (ANT) priced its initial public offering at $83 a share on November 18, above its $70 to $78 target range, a person familiar with the matter said. The offering was increased in size, the person said, in one of the largest stock-market IPOs on record and the first by a major frontier AI model developer.
  • Wall Street's $500 billion Nvidia (NVDA) chip financing initiative stalls: A pledge from Wall Street firms to secure $500 billion in financing for Nvidia chips has failed to materialize, according to the Wall Street Journal. Former CEO Jensen Huang secured commitments from Apollo Global Management, Blackstone, BlackRock, Brookfield Asset Management, Goldman Sachs and KKR in August, with the capital intended for AI customers including OpenAI and Anthropic. No funds have been deployed, the Journal reported, and investor doubt is growing about whether the program will proceed following Huang's exit https://tinyurl.com/29u9ktsp
  • Palo Alto Networks (PANW) Q1 Adjusted EPS $1.05 vs. est. $0.97 (beat), revenue $3.445B vs. est. $3.307B (beat), adjusted operating Income $1.1B and next-generation Security ARR $9.73B, up 66% Y/Y; sees Q2 adjusted EPS $1.01-$1.03 vs. est. $1.01 (above at midpoint), revenue $3.53B-$3.55B vs. est. $3.42B (above) and next-generation Security ARR $10.20B-$10.22B; sees FY27 adjusted EPS $4.26-$4.30 vs est $4.18 (above), revenue $14.52B-$14.57B vs est $14.156B (above) and next-generation Security ARR $11.475B-$11.525B; announces $4.5B all-stock Applied Compute deal expected to close in Q3 FY27.
  • Everpure Inc. (P) Q3 revs $1.5B vs. est. $1.335B; Q3 adj gross margin 69.2% and Q3 adj Operating Income $345M vs. est. $273.7M; guides FY rev outlook $5.2B-$5.21B vs. consensus estimates of $5.06B and raises FY27 adjusted operating income view to $1.08B-$1.09B from $940M-$960M.
  • Kulicke and Soffa (KLIC) Q4 Adjusted EPS $1.52 vs. est. $1.43 (beat), revenue $410.3Mm vs. est. $376.8Mm (beat), and gross margin 47.8%; sees Q1 FY27 adjusted EPS $1.65 plus or minus 10% vs est $1.43 and revenue $410Mm plus or minus $20Mm vs est $373.3Mm.
  • Taiwan Semi (TSM) and Samsung suspend some chip shipments to Chinese customers, the Financial Times reported; both have halted deliveries of certain processors to Chinese customers while they apply for licenses from the U.S. Commerce Department.

Mid-Morning Look

Thursday, November 19, 2026

Index

Up/Down

%

Last

DJ Industrials

-139.13

0.28%

50,059

S&P 500

31.36

0.43%

7,354

Nasdaq

265.84

1.05%

24,687

Russell 2000

-3.29

0.12%

2,711

 

 

U.S. stock futures traded higher overnight, and the strength carried into the market open, particularly in the technology sector. Claude developer Anthropic (ANT) priced its IPO at $83 a share, above the earlier target range of $70 to $78—giving the company a fully diluted valuation of around $1.5 trillion. The offering has lifted sentiment across AI-linked equities to start the day, against five consecutive S&P 500 down sessions and hawkish October FOMC minutes. Also yesterday, October 27–28 FOMC minutes showed nearly all policymakers anticipated further tightening if the economy follows their projections, with larger hikes contemplated if inflation proves persistent. Data this morning showed weaker Philly Fed manufacturing data, but a rise in prices paid. Software stocks rebounding, particularly cyber security behind good results/guidance from PANW. Early strength all in the tech space (XLK +3%, SOX +4%, QQQ +2%) while most other S&P sectors are faltering (XLP, XLV, XLB). Wal-Mart (WMT) reported better quarterly results and raised guidance but saw shares slip initially.

 

The US dollar index (DXY) is slipping following a seven-session winning streak but remained underpinned by hawkish remarks from a Federal Reserve official that reinforced the case for further rate hikes. Fed Governor Christopher Waller called yesterday for a more aggressive response to inflation, while minutes of the central bank's October 27 to 28 meeting showed policymakers increasingly concerned that additional tightening might be needed. Despite the easing in the dollar, precious metals remain at more than 1 year lows. The dollar slipped as the Philadelphia Fed's factory index fell to 6.3 in November from 20.9, well below forecasts for 20, while initial jobless claims edged up to 203,000 last week from 202,000, above the 197,000 economists expected. Gold prices edged higher on Thursday as bargain hunting and short-covering emerged after a sharp selloff that drove bullion to a 14-month low, although a firm dollar and mounting expectations of tighter US monetary policy capped gains.

Economic Data

  • Weekly Jobless Claims climbed to 203,000 from 202,000 prior and above consensus 197,000; the 4-week moving average climbed to 197,750 from 195,750 prior week (previous 195,250); continued claims climbed to 1.763M (consensus. 1.710M) from 1.693M prior week.
  • Philadelphia Fed business conditions November falls to 6.3 from 20.9 in October and below consensus 20.0; prices paid index November jumps to 58.2 vs October 43.2; new orders index November -0.4 vs October 4.3; employment index November 11.6 vs October 9.1; six-month business conditions November 33.6 vs October 33.0 and Philadelphia Fed six-month capital expenditures outlook November 18.9 vs October 34.9.

 

 

Macro

Up/Down

Last

WTI Crude

1.52

84.78

Brent

1.28

93.23

Gold

-32.10

3,709.80

EUR/USD

0.0015

1.0989

JPY/USD

0.65

159.92

10-Year Note

0.03

5.10%

 

Sector Movers Today

  • Metals & Mining sector: UBS noted key metals including copper, gold, aluminium & Silver are down 8 15% over the last 3 weeks, with copper/aluminium recently breaking key technical support levels triggering further long liquidation. The firm says the unwind of the Ai trade, US mid-terms & US CPI print causing a repricing of the Fed have acted as key catalysts. UBS believes global macro events triggering positioning reset (vs stale longs in copper) are largely responsible for the correction vs clear evidence of material demand weakness. No real bounce in precious metals this morning with gold/silver miners sliding.
  • Insurance brokers: Wells Fargo with several changes as they downgraded AJG to Equal Weight from Overweight (sees slowing brokerage organic growth for Arthur J. Gallagher), AON also cut to Equal Weight (as expects "noise and volatility" in Aon's price); while upgraded BRO to Overweight from Equal Weight (tgt to $82 from $68) and MRSH upgraded to Overweight (tgt to $235 from $197), saying brokers remain its favored sub-sector, with WTW their top idea. Notes The BRO has a "low bar" for its organic growth heading into 2027, given the weakness seen over the past couple of years; sees earnings upside for Marsh in 2027 from the AltamarCAM and Wilshire acquisitions.
  • Insurance sector: RGA was upgraded to Buy and raise PT to $325 from $236 at UBS as believe the market is overlooking the combination of 1) upside from continued mortality improvements (~5 points of upside to 2027E), and 2) upside from the EQH deal accretion (~2 points of upside). UNM was upgraded from Neutral to Buy at UBS and raise tgt to $111 as believes the market is underappreciating ~8% potential upside to 2027 cons. EPS from improving mortality. At the same time, risk transfer has significantly reduced LTC risk, with ~70% of the block now in the lower-risk group category. ALL announces October estimated catastrophe losses of $232M, or $184M after-tax.
  • Managed care: the sector was pummeled the last two days (ELV, UNH, CI, HUM, CNC, MOH, CVS). Goldman Sachs said today they see the sharp sector selloff following the Blue Sweep and CRUSH/RADV proposal as reflecting greater policy uncertainty rather than a comparable deterioration in earnings fundamentals. The firm sees the $9bn annual RADV recovery assumption as difficult to reconcile with current MA profitability and improving MA improper-payment rates, while Medicaid names benefit near term from delayed work-requirement pressure. View the pullback as a buying opportunity in UNH with CVS also offering significant upside from current levels.

 

Stock GAINERS

  • AMBA +12%; shares jumped on a report that the company may be in the final stages of a deal to be sold to NXPI, per Betaville. Betaville reported late last month that Ambarella (AMBA)was speculated to be in exclusive talks with NXPI. https://tinyurl.com/khpbtctd
  • ASTS +6%; was upgraded from Neutral to Buy at B Riley and maintains $48 tgt noting shares have fallen 55% since the firms downgrade on 10/1, versus a 3.3% decline in the Russell 2000 and believes the selloff prices in much of the risk around capital commitments, Constellation deployment.
  • NVDA +3%; amid a broad rebound to start the day for the AI complex and semiconductors (SOX, SMH) ahead of the Anthropic (ANT) IPO which priced well above its expected range.
  • P +10%; after delivered a strong quarter, with revenue upside accelerating vs prior periods, reinforcing management's bullish Investor Day outlook; FY27 revenue and adjusted operating Income outlooks came in roughly $155M and $140M above consensus, respectively.
  • PANW +6%; as delivered a strong Q1 print, punctuated by NGS ARR (+66%-Y/Y), Product Revenue (+37%-Y/Y), Total Revenue (+39%-Y/Y), and EPS above consensus; saw broad-based traction across the platform (Network/AI Security, Cortex, Idira); Q2 guidance was above expectations and announced the $4.5B acquisition of Applied Compute.
  • PDD +11%; shares rose after Q3 adj profit topped consensus as the company cut sales and marketing spending; adj net profit was 31 billion yuan ($4.65 billion) for Q3 vs. consensus estimate of 28.03 billion yuan and revs of 108.3 billion yuan ($16.25 billion) topped consensus of 115.97 billion yuan.

 

Stock LAGGARDS

  • BBWI -2%; posted Q3 sales $1.58B vs. est. $1.55B but forecasts wider-than-expected decline in Q4 net sales amid early stages of turnaround; now sees Q4 net sales to decline between 2%-5.5%, compared with estimates of a -2.7% drop and narrows year sales view.
  • DKS -2%; was downgraded to Sell from Hold and cut tgt to $120 at Williams Trading ahead of earnings saying the company's FY27 outlook is about to get worse as weak back-to-school traffic and elevated inventory levels at Foot Locker will result in Dick's either missing or coming in at the low end.
  • NTES -9%; posts adj. EPS of 14.21 yuan ($2.13) compared to the analysts' estimate of 16.11 yuan ($2.42); Q3 revenue of 27.9B yuan ($4.2B), missed analysts' consensus of RMB 30.2B yuan ($4.53B); said results weighed down by a fall in revenue generated by NetEase-owned Education tech company Youdao.
  • NVS -2%; as set a target of annual sales growth of 5% through 2031, which is lower than a 5% to 6% annual sales growth range it set last year for 2025-2030.
  • RRGB -24%; after results miss; posted a wider than expected Q3 EPS loss (-$0.54) vs. est. loss (-$0.34); Q3 revs fell -12% y/y to  $232.1M vs. est. $253.6M; Q3 FY26 net loss widened 15% y/y to -$21.19M.
  • SLS -12%; after selling 11.5M shares of stock at $13, a 27.6% discount to last sale. SLS shares surged 156% to finish at $19.15 on Tues its blood cancer vaccine, galinpepimut-S, extends survival in late-stage trial
  • WSM -6%; shares fell after Q3 EPS reported in-line and slight sales miss of $1.99B vs. estimates $2.0B while reiterates annual comparable sales growth forecast in the range of 4% to 6.5%, and comp sales up 4%-6.5%, but says will provide fiscal 2027 forecast in March.

Closing Recap

Wednesday, November 18, 2026

Index

Up/Down

%

Last

DJ Industrials

-561.64

1.11%

50,197

S&P 500

-17.03

0.23%

7,323

Nasdaq

101.50

0.42%

24,429

Russell 2000

12.44

0.46%

2,714

 

 

 

 

 

 

 

 

 

U.S. stocks finish mostly lower as the S&P 500 (SPX) declined for a 5th straight day, beaten down on rising rate hike fears from the Fed in December/looking forward, while a strong earnings report and upbeat guidance from AI bellwether Nvidia (NVDA) failed to re-energize the AI trade. All eyes now on the expected pricing of the Anthropic (ANT) IPO tonight in the Ai sector. Earnings results in the retail space this morning saw shares of Target (TGT) and TJ Maxx (TJX) moving higher while Lowe’s (LOW) reported a beat but only maintained guidance weighed on shares. Tomorrow morning in retail, WMT, BABA, WSM, among earnings expected out. The Nasdaq Comp snapped its 4-day losing streak with a modest gain led behind mage cap tech (AMZN, GOOGL, TSLA) helping offset the general weakness in the AI and chip sector despite the NVDA beat and raise report. The Dow Jones Industrials was pressured by significant pressure in UnitedHealth (UNH) after news Tuesday that the Trump administration announced plans for a widespread crackdown targeting fraud and Waste across federal and State-sponsored health programs, including Medicare, Medicaid & Health Insurance Marketplace, while Smallcaps outperformed (IWM). Commodity prices were broadly lower (metals, energy, softs, grains) amid the tough rate talk by the Fed.

 

Stock markets were spooked early after Federal Reserve Governor Christopher Waller called for aggressive action against inflation, saying the central bank needs to “shock people” as prices continue to rise more than he expected. In the near term, the policymaker told CNBC in a live interview that a half percentage point increase in the Fed’s benchmark rate is probably necessary at the Dec. 8-9 meeting of the Federal Open Market Committee. He said the central bank needs to reverse the three quarter-point reductions from last year and may need to do more. Waller said annualized inflation is tracking toward 3.5% and that roughly 70% of core services items are running above 3%, unrelated to oil. Markets did not like these comments as precious metals tumbled and the dollar rose. Later in the day, the FOMC minutes from the October 27–28 meeting confirm the hold was a pause, not a pivot, in line with recent Fed speak, and “a couple” were already talking about a bigger move in December.

 

Better NVDA results and guidance wasn’t enough to turn sentiment in the semi/AI sector today. Nvidia delivered a beat-and-raise and provided another set of data points confirming the Ai infrastructure demand environment; Q327 revenue of $115.8B (+20% q/q) beat the top end of guidance by ~$5.7B, with Hyperscale (+23% q/q) driving the upside and Vera Rubin contributing nearly $20B in its first production quarter; Q3 Data Center revenue rose 110.5% y/y to $107.6B, tops consensus of $101.87B; non-GAAP GM of 74.9% beat the guide by ~90bps; Q4 guide of $130.0B is ~4% above consensus, and FY28 growth was raised to ~75% from ~70%, while the 71–72% FQ4 GM trough and 72–73% FY28 range were reaffirmed. Open models are accelerating. Ai adoption and weekly Token volume on OpenRouter have surged 35x y/y and 3.5x in just these past three months. Commitments associated with neocloud agreements totaled $32B at the end of Q3. Total guarantees were $118B at the end of Q3, including the $105B in credit support for Land, power, and Shell capacity.

 

Next potential market catalyst…Anthropic (ANT) as CNBC reported that the Claude owner is considering expanding its IPO and pricing shares well above $80. CNBC said Institutional demand has reportedly reached $400 billion, with retail orders approaching $100 billion, although indications of interest are nonbinding. The company initially planned to raise up to $64.35 billion by selling 825 million shares. Anthropic reported $33.24 billion in nine-month revenue, up approximately 1,200%, with an October revenue run rate of $81 billion. Final pricing is expected Wednesday, ahead of Thursday's Nasdaq debut.

 

Minutes from the October FOMC policy meeting showed Fed policymakers focused on inflation risks in October, with some seeing need for bigger rate hike. Federal Reserve officials saw a growing risk last month that they might need to intensify their efforts to control inflation, even as they agreed to keep interest rates steady for the moment, the minutes of their October 27-28 meeting showed. "Almost all" policymakers agreed that further rate hikes would be needed if the economy evolved as they expected, the minutes said, while a few said inflation could prove more persistent and require "a shift to a more restrictive policy stance" than currently expected. "A couple" of them went further and argued that the Fed might have to resort to a half-percentage-point increase "if incoming inflation data were unfavorable." At the end of the two-day session, only Fed Governor Lisa Cook and Cleveland Fed President Beth Hammack dissented in favor of lifting the policy rate by a quarter of a percentage point.

Economic Data

  • October housing starts climbed 9.9% M/M to a seasonally adjusted annual rate of 1.309M in October, beating the 1.230M consensus, from 1.191M prior (revised from 1.221M). The rate of housing starts was 2.8% above the year-ago level. Single-family housing starts grew 4.0% M/M to 864K.
  • October Building permits increased 7.4% M/M to SAAR of 1.295M in October, missing the 1.378M consensus, from 1.398M prior (revised from 1.400M). Single-family authorizations stood at 772K, or 8.7% lower than the revised September figure.
  • October pending home sales -4.7% m/m vs. -2.0% est. & -7.2 prior as the index level dropped to 63, its lowest on record.
  • MBA Mortgage Applications data for the week ended Nov 13 showed the market index fell -2.3% to 199.8, with the purchase index down -2.5% to 137.6 and the refinance index down -1.5% to 532.8; the average 30-year mortgage rate climbed 14 basis points to 7.35%.

Commodities

  • Brutal day overall for commodity prices on higher rate outlook by the Fed as Gasoline -2.1%, Heating Oil -1.8%, Gold -3.2%, Platinum -4.3%, Silver -5.2%, Copper -5.4%, Coffee -2.1%, Corn -2.4%, Cotton -3.1%, Wheat -3.90%.
  • Gold fell below $3,800/oz for the first time since September 2025 as the barrage of Fed speak continues this week, with a December move fully priced and more than 80bps of tightening seen by September 2027. December gold fell -$122.30, or -3.16%, to settle at $3,741.90 an ounce. Fed's Williams speaking late in the US session said the economy is strong and getting stronger, inflation is not moving in the right direction. Fed still has more work to do to get inflation back to 2%. Platinum extended its slide, falling $64.60, or 4.5%, to $1,361.90 an ounce after touching $1,354.90, with spot prices at their lowest since late September 2025.
  • Gold, silver and other precious metals remain in a massive drawdown, as investors remain concerned about the Fed fighting inflation, with calls for more aggressive rate hike in December and into 2027 to get inflation lower. The calls have led to a surge in the U.S. dollar and Treasury yields which in turn have crushed precious metal prices.  According to UBS, three headwinds help explain the gap between gold's narrative and its performance as it trades at lowest levels since Sept ‘25: 1) the biggest has been the sharp shift in Fed policy expectations, 2) the subsequent rise in yields and 3) the ongoing hiking Cycle. Real rates are simply too high for investors to ignore. The Dollar has added to the pressure: although currency-specific factors have made index moves choppy, the overall bias has been towards a stronger Dollar. The third headwind is competition for investors' attention. Ai and energy have drawn focus away from gold/precious metals complex.
  • Oil prices tumbled following weekly inventory data that showed a surplus supply outlook. WTI crude ended the day down $2.75, or 3.20% to settle at $83.26 after earlier falling below $82/barrel for the first time since August 27th. Gas prices just posted their largest single-day drop in 18 years. Oil prices were down initially but added to declines after large weekly crude build. The EIA said U.S. weekly crude stocks up 3.4M bbls to 417.8M, vs forecast of 0.1M bbl build while U.S. weekly gasoline stocks up 5.2M bbls to 215.95M, vs forecast of 1.6M bbl build. Brent Crude futures settle at $91.95/bbl, down $1.19, or 1.28%.

Currencies & Treasuries

  • The U.S. dollar index (DXY) touched a fresh 19-month highs amid more hawkish Fed commentary this morning, which was confirmed by a higher rate outlook shown in the October FOMC policy minutes this afternoon. The euro fell to a new YTD low of 1.0960 this morning. Sterling was also weak after the market interpreted UK CPI as modestly dovish. The data was broadly in line but softer underneath, with services at 3.7% vs 3.8% expected. Food prices eased, while the headline rise was largely fuel/tax driven.
  • US Treasury yields were slightly lower as oil prices dropped, while comments from Federal Reserve governor Christopher Waller that the central bank needs to approve a 50 bps interest rate hike at its December meeting or communicate a faster pace of hikes in 2027 limited the decline. The yield on the benchmark US 10-year Treasury note was down 3.6 bps at 5.065%. Yields initially rose after Waller said on CNBC that the central bank needs to get more aggressive in its response to inflation, but later pulled back.
  • The Fed left rates unchanged at its October meeting, and markets have largely been expecting a 25-basis-point rate increase in December. Fed funds futures traders on Wednesday were pricing in a roughly 95% chance of a 25-basis-point hike at the US central bank's December 8-9 meeting, according to the CME Group's FedWatch Tool, and about a 5% chance of a 50-basis-point hike.
  • Bitcoin prices tumbled along with precious metals as rising rate hike fears takes a further bite out of the crypto sector. Bitcoin fell more than -2.7% to lows around $62,500 and Ethereum down over -3% to $1,750, before a late morning pop pared the losses.

 

Macro

Up/Down

Last

WTI Crude

-2.75

83.26

Brent

-1.19

91.95

Gold

-122.30

3,741.90

EUR/USD

-0.0033

1.097

JPY/USD

-0.05

159.34

10-Year Note

-0.036

5.065%

 

Sector News Breakdown

Retail, Consumer Staples & Restaurants:

  • Hardline retailers: TGT raised its annual net sales growth forecast to around 6%, from about 5% prior, after Q3 comp sales rose 5.6% and beat estimates of 3.5%; reported its third consecutive strong sales quarter and projected adjusted earnings per share of $10.65 to $11.40 above prior forecast $9.90-$10.90 (est. $10.56)
  • Off price retail: TJX shares jumped on results after posted in-line Q3 EPS results and better sales, while revises its FY sales growth outlook to top end of guidance even though guided Q4 comp sales growth 0f 2%-3%, below the consensus view of 3.16%; says it expects sales momentum for its portfolio of off-price stores to accelerate throughout the key holiday shopping period.
  • Online retailers: JMIA shares fell after saying GMV growth in the first weeks of Black Friday event, which started at the end of October, has been well below expectations and Q3 and October trends; Higher memory chip costs reduced supply of affordable smartphones and electronics, weighing on customer acquisition and engagement.
  • Food sector: BRBR shares rise after Q4 sales beat $692M vs. estimate $657.2M and adj EBITDA of $66.4M topped estimates, while the company names Travis Leonard as CFO. CALM said an avian flu outbreak at one of its Florida facilities will require the company to depopulate about 1.76 million birds. The birds include roughly 1.4 million laying hens and 360,000 pullets, representing about 2.7% of the company's total flock, the egg producer. Production at the facility has temporarily ceased as Cal-Maine follows protocols.

Homebuilders, Building Products, Home Furnishing:

  • Home improvement retail: LOW Q3 adj EPS $3.10 tops consensus $2.88 on better revs $22.76B vs. est. $22.36B; Q3 comp sales rose +1.8%, driven by a 17.4% increase in online sales; raises FY26 revenue view to $92.5B from $92B, vs. consensus $92.02B but shares weaker after only maintains its FY earnings outlook despite beat as outperformance during Q3 was largely due to a $250 million tariff refund, which boosted adjusted earnings by 34 cents a share. Excluding that tariff refund, earnings underwhelmed.
  • Furniture sector: LZB reported F2Q (Oct-ended) revenue and EPS above consensus, driven by strength within the Wholesale segment. Written same-store sales for the Retail segment declined 1.0%, as strong trends in August and September were offset by weakness in October, Looking ahead, LZB’s F3Q sales guidance and implied EPS are below consensus.

Energy, Industrials

  • Energy & Equipment: CNX was upgraded to Equal Weight from Underweight at Morgan Stanley citing the company's hedge protection at lower gas prices for the upgrade. CNX's edge profile supports stable cash flow even at lower Henry Hub prices. The firm downgraded CRK to Underweight from Equal Weight citing the company's 2027 outspend and 20% premium to strip net asset value for the downgrade.  Oil refiners extend recent tumble off all-time highs last month on weaker crack spread (VLO, MPC, DK, PBF).
  • AI Infrastructure sector: Deutsche Bank said the most important read-through from SuperCompute trade show was the absence of signs that customers are pulling back on infrastructure investment, contrary to recent market concerns. DBAB noted NVT said customers are looking to accelerate, rather than delay, data center buildouts, are being very aggressive around deployments, and are increasingly exploring Modular/e-house approaches to shorten construction timelines. VRT's commentary was similarly positive: data Centers continue to become larger, denser, and more thermally challenging, with the pace of architectural change accelerating. In other news, GEV was downgraded from Buy to Hold at Erste Group as sees Ge Vernova as a leader in Grid modernization, but management expects new orders to grow more slowly in 2027 despite a strong order book. They also downgraded ETN from Buy to Hold as flags the balance-sheet cost of acquisition-led expansion: long-term liabilities doubled within a year and goodwill rose sharply.
  • Aerospace & Defense sector: TXT agreed to sell its industrial business to an affiliate of Kingswood Capital for $1.2B in cash. Industrial business designs and manufactures specialized vehicles, turf-care equipment and plastic fuel systems; had announced in April it would streamline operations by separating the unit. Post sale, co to focus on aerospace and defense operations, including Textron Aviation, Bell and Textron Systems. SPCX shares rallied as Texas environmental regulators issued an air pollution permit Monday to SpaceX data center and gas-fired power plant planned for the Rio Grande Valley, saying they have “resumed” permitting of supercomputing facilities after Republican Gov. Greg Abbott ordered the agency to pause approvals in September. The permit clears a major regulatory hurdle for the $24 billion project.

Financials

  • Brokers & Exchanges: SCHW was upgraded to Strong Buy from Outperform as views Schwab as a clear beneficiary from higher-for-longer interest rates which should drive continued healthy net interest margin expansion. Beyond macro tailwinds, Schwab's account and net new asset growth rates are healthy and prove the company's value proposition with Self-directed retail investors and RIAs remains strong.
  • Crypto sector: Bitcoin prices dropped below $63,000 this morning, weighing on the crypto sector as MSTR drops to low $90’s level and COIN hits 52-week lows; BLSH posted Q3 GAAP EPS of $3.57 beats by $2.22 and revs up 10% y/y to $84.4M (+10.3% Y/Y) beating as well as both transaction and subscription and services revenue were stronger than expected. Meanwhile, its operating expenses were lower than the Wall Street consensus.
  • FinTech sector: KLAR Q3 revenue rose 12% y/y, beating analyst expectations, while adj operating income turned positive, up $35M y/y to $21M and Q3 GMV increased 10% y/y to $36.1B; also reiterates 2026 GMV guidance and maintains 2026 revenue forecast of $4.08B-$4.16B. Merchant network grew 59% y/y to 1.35M, driven by integrations with major payment providers and new partnerships.
  • Banks: Reuters reported ECB policymakers are set to discuss next week raising minimum reserve requirements for euro zone banks, a move that would reduce the ECB's interest bill and withdraw some liquidity from the financial system. The change, to be debated at a Governing Council meeting on November 25, would raise the share of cash that commercial lenders must keep in an unremunerated account to 2% from 1% of deposits and other short-term liabilities, the sources familiar with the discussions said. They added a decision may be pushed back to the December 17 policy meeting.

Biotech & Pharma:

  • ARDT shares declined after pricing 8M share Spot Secondary priced at $14.50 (deal size rose to 8M from 7M shares) - prior day close was $17.75.
  • BIIB presented two-year, open-label extension results from the same study, with diranersen’s disease-slowing benefit now boosted to 38%. The comparison this time were patients who were originally assigned to placebo, but who transitioned to diranersen at 18 months.
  • MDLN prices secondary offering of 60M Class A shares at $35.5 per share.
  • PFE entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics; Starna will receive an upfront payment of $330M and is eligible to receive up to $2.3B in milestone payments plus royalties.
  • RXRX aligns with the FDA on a registrational Phase 3 trial design for REC-4881 in familial adenomatous polyposis, with enrollment of 200 adults set to begin in the second half of 2027.
  • SMMT shares fell after the FDA publishes letter outlining reasons to decline approval for Summit's experimental lung cancer drug ivonescimab. The FDA says application relied on study with about 60% China enrollment, later amended to add North America and EU patients. FDA notes 17-month gap between first patient enrollment in China and North America/EU

Healthcare Services & MedTech movers:

  • Managed care sector: ELV was upgraded to Buy from Hold at Argus saying Elevance is on the path to improve profitability, who sees stronger EPS growth in 2027 as corporate actions to improve operating margins gain traction. The managed care sector adds to the prior day declines where UNH, CVS, CNC, MOH, HUM and others declined after the Trump administration announced plans for a widespread crackdown targeting fraud and Waste across federal and State-sponsored health programs, including Medicare, Medicaid & Health Insurance Marketplace.
  • Insulin sector: Stifel upgraded TNDM to Buy from Hold and downgraded PODD to Hold from Buy in insulin sector. For Insulet, Stifel's diligence suggests that new entrants will expand the tubeless pump market, but it will not be enough to offset future share losses. For future tubeless entrants, Tandem's tubeless Mobi (Tobi) scored well, with 2028 share ahead of Fit and Mint and is expected to capture 29% of 2028 tubeless Ncs.
  • Medical Equipment: HAE receives CE Mark certification for its VASCADE MVP XL venous vascular closure system, enabling European expansion after completing first procedures in Germany, Italy and the UK in October.

Materials, Metals & Mining

  • Metals & Mining:  Copper futures sank to their lowest since April as a stronger dollar, weaker sentiment around AI-related assets, and concerns over Chinese demand weighed on the market. The latest declines came after Stan Druckenmiller said late Tuesday he had turned bearish on the metal, adding to a chorus of concerns about the trajectory of growth in the AI sector. Copper prices meanwhile tumbling and FCX was downgraded from Buy to Hold at Erste Group saying they expect lower 2026 copper and gold production as its Indonesian operations gradually ramp. Management forecasts $8.3B of 2026 operating cash flow. Erste Group expects copper and gold prices to move sideways in the coming months.
  • Precious metal sector: more weakness in precious metals (and miners AEM, B, CDE, GOLD, NEM, HL, WPM, PAAS and others) as the dollar and Treasury yields rise on more hawkish Fed commentary on rates and expected rising rates in December. However, UBS notes prices have fallen to their lowest levels since late 2025 and are down more than 30% from the all-time high reached at the start of this year…but forecasts gold reaching $4,600 by June 2027 and $5,000 by December, supported by central-bank buying, Chinese demand and expectations of easing U.S. real yields. The bank also sees silver rising to $65 per ounce and copper reaching $15,500 per ton by year-end. The outlook favors precious and industrial metals over oil, although geopolitical disruptions and persistent Fed tightening remain key risks.

NVDA and quarterly implications for other sectors

  • Nvidia the story today – recap of its earnings, guidance, and key parts of commentary:
  • Neocloud (NBIS, CRWV, IREN, APLD) rise after NVDA noted in its earnings release that they have partnered with leading neoclouds to enable broader access to our Ai infrastructure to serve Ai startups, model Builders, enterprises, research organizations and sovereign customers. NVDA said their commitments take effect only if the neoclouds secure financing to purchase the data center infrastructure products and the related compute capacity is deployed, made operational, and accepted by US. NVDA says its agreements with neocloud providers total $32 Billion. Cantor noted the data points that drive neocloud and PSP economics were all positive, and in several cases the strongest NVDA has ever given.
  • 1) NVDA raised its FY28 revenue growth outlook to ~75% (prior ~70%) and Evercore said it views the stronger growth outlook as positive for supporting power/cooling, connectivity and networking demand across VRT, APH, TEL, ANET, CIEN and CSCO
  • 2) NVDA disclosed 32B of contingent neocloud commitments and $118B of guarantees and Evercore views efforts to unlock Land, power and financing as constructive for the broader neocloud ecosystem, including CRWV, and infrastructure suppliers such as VRT.
  • 3) Aci&E revenue grew 18% q/q and 195% Y/y to $47.5B, Evercore views broader adoption as positive for DELL and continued neocloud expansion as supportive for CRWV.
  • 4) NVDA networking revenue exceeded $21B, while scale-out CPO entered volume production, with Lambda deploying Nvidia Photonics switches connecting over 10,000 GB300 GPUs - Evercore continues to view Ai networking investment as a rising Tide for ANET, CIEN and CSCO, although NVDA's expanding networking portfolio also reinforces the competitive backdrop.

Media, Hardware & Software movers:

  • Optical sector: AAOI shares tumbled after filed a prospectus supplement for a new $550 million at-the-market (ATM) equity offering, allowing it to sell shares over time at prevailing market prices.
  • Media sector: NYT was downgraded to Neutral at Citi, price target cut to $76, as the firm flags eroding app downloads, active users, engagement frequency and time, organic web visits, and decelerating subscription and ad ARPU monetization trends. NMAX sued FOXA on Wednesday to block its $22B takeover of Roku, alleging the deal hurts competition in the fast-growing market for free, Ad-supported television. Fox announced on November 6 that it had completed the acquisition, earlier than the companies had publicly projected after months of regulatory scrutiny, as per the lawsuit.
  • Software sector: TTWO shares jump as its “Grand Theft Auto VI," made by co's Rockstar Games, will be released at midnight across markets on Thursday, starting with New Zealand. Analytics firm Sensor Tower estimates close to 16Mm copies sold for more than $1.5B as of Tuesday, two days before release. The game comes after 13 years and an estimated $1B or more in production costs.

AI sector:

  • Anthropic (ANT) up next as CNBC reported that the Claude owner is considering expanding its IPO and pricing shares well above $80. CNBC said Institutional demand has reportedly reached $400 billion, with retail orders approaching $100 billion, although indications of interest are nonbinding. The company initially planned to raise up to $64.35 billion by selling 825 million shares. Anthropic reported $33.24 billion in nine-month revenue, up approximately 1,200%, with an October revenue run rate of $81 billion. Final pricing is expected Wednesday, ahead of Thursday's Nasdaq debut.
  • A report in The Information noted ByteDance is in advanced talks to spend an additional roughly $500M on Cloud services from Microsoft, primarily to use OpenAI models from Microsoft’s Azure Cloud, according to two people with knowledge of the situation. The move to expand the Chinese firm’s already large contract with Microsoft has drawn the ire of OpenAI. https://tinyurl.com/256jnzkn
  • CRDO announced that it has reached an agreement with MRVL regarding the parties' respective patent rights related to Active Electrical Cable technology.

Not offered or endorsed by Regal Securities

Street Recommendations

Thursday, November 19, 2026

ARGUS

  • IP Argus downgraded International Paper to Hold from Buy. The company has a strong record in the industry, but its earnings have been hurt by higher input costs, tariff uncertainty, and a soft demand environment, the analyst tells investors in a research note. International Paper's recent DS Smith acquisition is underperforming and providing less value than the market initially anticipated, the firm added. Argus further notes that with the lagging global market recovery, the company has been forced to engage in heavy capital investment to make operational improvements.
  • ADTN Argus downgraded Adtran to Sell from Hold.

B. RILEY

  • ASTS B. Riley upgraded AST SpaceMobile (ASTS) to Buy from Neutral with a $48 price target. Many of the capital commitment and constellation deployment fears underlying the firm's prior action, as well as new fears regarding the rocket development partnership with Firefly Aerospace (FLY), are already priced in, the analyst tells investors in a research note. The firm sees a much improved risk-reward equation and thinks investors are overlooking potential fruits of successful rocket development and other positive catalysts.

BARCLAYS

  • CTVA Barclays reinstated coverage of Corteva with an Equal Weight rating and $11 price target. The firm cites the company's weaker than expected Q3 results and "surprise" guidance cut for the neutral rating. Barclays expects Corteva revenue to grow at 2% annually post 2026, with 2029 levels settling about 6.5% below the company's long-term guidance.
  • SNPS Barclays initiated coverage of Synopsys with an Overweight rating and $640 price target. The company is the leader in the growing electronic design automation market, which is seeing accelerating semiconductor spend, the analyst tells investors in a research note. The firm says Synopsys has the top market share in this duopoly market, making it one of the more attractive competitive landscapes in software.
  • ELAN Barclays raised the firm's price target on Elanco to $32 from $30 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q3 report. Elanco's growth outlook continues to demonstrate strength from recent launches with "ample share gain opportunity ahead," the analyst tells investors in a research note.
  • LOW Barclays analyst Seth Sigman lowered the firm's price target on Lowe's to $255 from $260 and keeps an Overweight rating on the shares. The company's Q3 sales were strong, while its margins were mixed due to timing of refunds and other cost pressures, the analyst tells investors in a research note. Barclays upped Lowe's fiscal 2026 estimates to reflect stronger sales but lowered fiscal 2027 estimates citing cost pressures.
  • PANW Barclays raised the firm's price target on Palo Alto Networks to $385 from $375 and keeps an Overweight rating on the shares. The company's fiscal Q1 net new annual recurring revenue of $630M was well ahead of Barclays' $450M estimate and it raised guidance by more than the beat, the analyst tells investors in a research note. The firm says the Applied Compute acquisition brings a large addressable market and more insight on agentic training.
  • TEVA Barclays raised the firm's price target on Teva to $50 from $47 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q3 report. Teva is closing out another year with "innovation firing on all cylinders," the analyst tells investors in a research note. Barclays sees a "more steady trajectory" upward for the shares from here.
  • FMX Barclays analyst Benjamin Theurer upgraded Femsa to Overweight from Equal Weight with a price target of $155, up from $140. The firm cites improving traffic at OXXO and the company's "scaling" digital ecosystem for the upgrade. OXXO Mexico has returned to positive traffic and stronger demand for cheaper products should support the business through at least the first half of 2027, the analyst tells investors in a research note.

BERNSTEIN

  • BRBR Bernstein analyst Alexia Howard raised the firm's price target on BellRing Brands to $15 from $13 and keeps a Market Perform rating on the shares. BellRing seems to be getting back on track after a brutal 18 months of disruptive competitive entry into the protein shake category, the firm says. But this quarter, the company stepped up promotional activity, even as input and freight costs intensified. As a result, organic sales growth accelerated to 6.8% from 4.2% last quarter and consumption was up by 8.8%, but some of this surge was likely driven by a step-up in promotional activity which brought Premier Protein's price/mix down 8.6% and goosed volume growth to 16.0%.
  • PANW Bernstein raised the firm's price target on Palo Alto Networks to $368 from $351 and keeps a Market Perform rating on the shares. Palo Alto's Q1 2027 started with a bang, as Net New organic NGS ARR accelerated to over 60% in a traditionally slower quarter, proving the strength in Q4 didn't "pull forward" too much and guidance indicated the strength should continue, the firm says. Moving towards Q2, Chronosphere becomes part of the organic revenue, which helps Bernstein justify its modeled second straight quarter of 60%-plus Net New ARR growth. The firm anticipates Chronosphere benefits from tailwinds in their largest AI Lab customer, which it believes to be OpenAI.

BMO CAPITAL

  • BE BMO Capital upgraded Bloom Energy to Outperform from Market Perform with a price target of $230, down from $260. The firm notes it had been more cautious on the stock, questioning the company's large-scale proof of concept, the durability of a higher-cost generation solution once grid availability improves, and the reliance on U.S. data center demand. While these debates remain, shares have pulled back, and large projects, including Nebius, are increasingly providing the execution evidence that BMO had previously wanted to see, the analyst tells investors in a research note. Risk-reward on the stock has turned more attractive, BMO added.

BOFA

  • VRT BofA analysts removed Vertiv from the firm's "US 1 List," which represents its best investment ideas.
  • VRDN BofA initiated coverage of Viridian Therapeutics with a Buy rating and $47 price target.
  • PANW BofA analyst Tal Liani raised the firm's price target on Palo Alto Networks to $430 from $420 and keeps a Buy rating on the shares. Palo Alto delivered a strong fiscal Q1 with broad based upside and an improved outlook, notes the analyst, who adds that accelerating revenue and RPO indicate the threat environment supports both near term spending and longer-term vendor consolidation.
  • MELI BofA analyst Robert Ford Aguilar lowered the firm's price target on MercadoLibre to $2,000 from $2,400 and keeps a Buy rating on the shares. The firm lowered its 2026-28 EPS estimates as MercadoLibre defers monetization and reinvests to widen moats and establish greater industry leadership, the analyst tells investors.
  • MDB BofA lowered the firm's price target on MongoDB to $450 from $540 and keeps a Buy rating on the shares ahead of fiscal Q3 results due on December 1. The firm, which thinks the bar for Atlas growth to be a catalyst has fallen to 29% year-over-year, which would hold growth flat with last quarter despite a slightly more difficult comparison, lowered its target on infrastructure peer group multiple compression.
  • EXPD BofA analyst Ken Hoexter raised the firm's price target on Expeditors to $234 from $230 and keeps a Buy rating on the shares. The company's first investor day in 11 years highlighted a structurally advantaged business, says the analyst, who notes that the company set targets for 5%-7% long-term organic revenue growth and 12%-15% EPS growth.
  • GLBE BofA lowered the firm's price target on Global-e Online to $50 from $52 and keeps a Buy rating on the shares. The company reported "slightly underwhelming" Q3 results, but "encouragingly" management increased 2026 guidance across the board by more than the Q3 beats, the analyst tells investors in a post-earnings note.
  • LOW BofA lowered the firm's price target on Lowe's to $250 from $251 and keeps a Neutral rating on the shares. Pro comps in Q3 were positive in the quarter, while DIY comps were slightly negative, similar to the last two quarters, notes the analyst, who forecasts Q4 comps to be up 0.2% as Lowe's laps 50 basis points of winter storm benefit last year.
  • PAYX BofA analyst Matthew O'Neill reinstated coverage of Paychex with a Neutral rating and $120 price target. Paychex remains "a quality franchise," but the firm sees a less compelling risk/reward as growth becomes more reliant on the Professional Employer Organization segment, the analyst tells investors.
  • CTSH BofA analyst Matthew O'Neill reinstated coverage of Cognizant with a Neutral rating and $70 price target. Clients increasingly seeking to capture the AI productivity dividend, while shifting more delivery risk to their vendors, leaves the integrator, rather than the model provider, accountable when AI-enabled deliverables fall short, argues the analyst, who thinks AI "represents a structural rather than cyclical headwind for the IT services industry."
  • ADP BofA analyst Matthew O'Neill reinstated coverage of ADP with a Buy rating and $345 price target. A highly recurring revenue model, strong client retention, robust cash flow generation, and leading scale across Human Capital Management combine to support "a durable growth and earnings profile," the analyst tells investors.
  • ACN BofA analyst Matthew O'Neill reinstated coverage of Accenture with a Buy rating and $288 price target. AI is accelerating industry consolidation as companies concentrate spending with fewer, larger partners, notes the analyst, who thinks Accenture has "the clearest right to win." C-suite relationships, as well as strategy through managed services breadth and partnerships with frontier labs, position Accenture to "build the enterprise AI technology stack and capture more of the transformation around it," the analyst tells investors.

BTIG

  • MDT BTIG analyst Ryan Zimmerman raised the firm's price target on Medtronic to $109 from $99 and keeps a Buy rating on the shares. At its Investor Day event next month, the company is expected to provide a number of updates, including a long-term growth and EPS target, capital allocation priorities, updates following the Diabetes separation, an in-depth look at the pipeline with particular attention paid to soft-tissue robotics, the analyst tells investors in a research note.
  • PANW BTIG raised the firm's price target on Palo Alto Networks to $442 from $425 and keeps a Buy rating on the shares. The company posted strong Q1 earnings and raised its FY27 outlook, the analyst tells investors in a research note. Importantly, strength was broad-based as SASE annual recurring revenue grew 30%, trailing 12-month firewall bookings rose 28%, Prisma AIRS reached nearly $170MM in ARR, and momentum remained strong across Cortex and Idira, the firm added.

CANTOR FITZGERALD

  • JMIA Cantor Fitzgerald analyst Deepak Mathivanan lowered the firm's price target on Jumia Technologies to $5 from $9 and keeps an Overweight rating on the shares. Jumia's growth outlook weakened on macro pressures, with Q4 GMV growth slowing to 4-8% and EBITDA losses widening to $4M-$8M, the analyst tells investors in a research note.
  • MOD Cantor Fitzgerald raised the firm's price target on Modexus Solutions to $200 from $178 and keeps an Overweight rating on the shares. The company's Analyst Day raised confidence in long-term earnings potential, with FY29 data center revenue targeted at $4.5B-$6.5B and 22%-24% EBITDA margins, the analyst tells investors in a research note.

CITI

  • PANW Citi raised the firm's price target on Palo Alto Networks to $445 from $440 and keeps a Buy rating on the shares following the fiscal Q1 report. The firm upped Palo Alto's estimates to reflect the biggest net new annual recurring revenue beat in three quarters. Citi views the Applied Compute acquisition as "unconventional" but consistent with Palo Alto's "long-game."
  • ARMK Citi lowered the firm's price target on Aramark to $72.50 from $75.50 and keeps a Buy rating on the shares. The firm's analysis of the company's new wins indicates accelerating growth in fiscal 2027 and 2028. Citi finds the shares attractively valued at current levels.

DZ BANK

  • F DZ Bank upgraded Ford to Buy from Hold with a $15 price target.

GOLDMAN SACHS

  • PANW Goldman Sachs raised the firm's price target on Palo Alto Networks to $440 from $390 and keeps a Buy rating on the shares. The firm sees additional 2027 upside as Applied Compute creates new opportunities to monetize AI token consumption through software firewalls, observability and Prisma AIRS, expanding beyond traditional per-user and ELA pricing models, the analyst tells investors in a research note.

GUGGENHEIM

  • TGT Guggenheim raised the firm's price target on Target to $180 from $175 and keeps a Buy rating on the shares. The Target story remains in "show me" territory with many investors, though the current valuation is "not necessarily indicative of doubt" and the stock's "hardly depressed levels" make further appreciation increasingly dependent on sales and bottom-line upside, the analyst tells investors.

JEFFERIES

  • PRIM Jefferies downgraded Primoris to Hold from Buy with a price target of $67, down from $99. The firm says the another renewables rebase from Primoris drives negative estimate revisions. Execution risks on bookings warrant a lower price target, the analyst tells investors in a research note. Jefferies awaits the company's energy bookings for more fiscal 2027 visibility.
  • PANW Jefferies raised the firm's price target on Palo Alto Networks to $450 from $400 and keeps a Buy rating on the shares. The company's fiscal Q1 core net new annual recurring revenue materially accelerated again driven by AI and observability tailwinds, the analyst tells investors in a research note. Jefferies says Palo Alto posted "another clean print" with "AI tailwinds starting to emerge."

JPMORGAN

  • XNCR JPMorgan raised the firm's price target on Xencor to $37 from $21 and keeps a Neutral rating on the shares. After speaking with two renal oncologists, the firm believes believe XmAb819's early activity in late-line clear cell renal cell carcinoma was a "compelling showcase on efficacy." However, additional color is needed on the durability of response and longer-term receptivity among physicians given the toxicity profile, the analyst tells investors in a research note.
  • PANW JPMorgan raised the firm's price target on Palo Alto Networks to $415 from $384 and keeps an Overweight rating on the shares. The firm says platformization and AI-enabled threat driven demand drove much better than expected annual recurring revenue, revenue, and profitability in fiscal Q1. JPMorgan continues to believe Palo Alto is well positioned to consolidate share in an environment that increasingly points to accelerating security spending into 2027.
  • BHVN JPMorgan analyst Tessa Romero raised the firm's price target on Biohaven to $35 from $14 and keeps an Overweight rating on the shares. The firm cites the FDA accepting for review the new drug application resubmission for Vyglxia in spinocerebellar ataxia for the target boost. JPMorgan believes there is the potential for upside from current share levels and remains positive on the stock heading into 2027.
  • TXRH JPMorgan lowered the firm's price target on Texas Roadhouse to $195 from $200 and keeps a Neutral rating on the shares post the Q3 report. The firm says a false brand allegation in August caused same-store-sales to weaken. However, Texas Roadhouse's quarter-to-date comps of 1.5% with sequential improvement into early November on lower price is promising, the analyst tells investors in a research note.

KEYBANC

  • IIIV KeyBanc raised the firm's price target on i3 Verticals to $23 from $20 and keeps an Overweight rating on the shares. The firm notes the company reported Q4 revenue and adjusted EBITDA 2%/6% above the Street. For FY27, revenue guidance was in line with the Street at the midpoint, while adjusted EBITDA and adjusted EPS guidance were above the Street at the midpoint.
  • PANW KeyBanc raised the firm's price target on Palo Alto Networks to $450 from $380 and keeps an Overweight rating on the shares. The firm notes Q1 results showed broad-based strength across the business, with many key metrics accelerating organically. KeyBanc believes the acceleration evidenced by Palo, and likely others this earnings season, is the beginning of a strong cyber investment cycle as the infrastructure is becoming increasingly vulnerable and the pace of AI-generated attacks having only recently started to inflect.

LOOP CAPITAL

  • UPBD Loop Capital analyst Casey Coates downgraded Upbound Group to Hold from Buy with an unchanged price target of $26.

MIZUHO

  • ROK Mizuho raised the firm's price target on Rockwell Automation to $415 from $375 and keeps a Neutral rating on the shares following the investor day. The company's margin targets moved higher across all three segments, solving to 25% enterprise operating margin after reaching its prior 22% target in three years, the analyst tells investors in a research note. Mizuho cites Rockwell 's higher operational framework and earnings prospects for the target boost.
  • PANW Mizuho raised the firm's price target on Palo Alto Networks to $440 from $415 and keeps an Outperform rating on the shares. The fiscal Q1 bar was very high but Palo Alto "ultimately delivered," the analyst tells investors in a research note. The firm remain bullish on the company's improving mix shift toward higher-growth recurring revenue.

MORGAN STANLEY

  • CAE Morgan Stanley upgraded CAE to Equal Weight from Underweight with a price target of C$44, up from C$37. The firm says the company's improving execution, transformation progress, and stronger balance sheet support a more balanced share risk/reward. CAE's transformation progress is ahead of plan, the analyst tells investors in a research note.

PIPER SANDLER

  • OTLK Piper Sandler initiated coverage of Outlook Therapeutics with an Overweight rating and $4 price target. The firm views Outlook as an "attractive and under-the-radar opportunity" into the pending U.S. launch of Lytenava. The drug recently became the first and only ophthalmic form of anti-VEGF therapy bevacizumab to gain FDA approval in retinal diseases, the analyst tells investors in a research note. Piper expects "significant migration" away from the compounded and repackaged forms of bevacizumab over to Lytenava. Feedback from a practitioner survey supports this view, Piper says.
  • KINS Piper Sandler analyst Paul Newsome initiated coverage of Kingstone Companies with an Overweight rating and $24 price target. The firm says the company has completed a turnaround after a failed expansion effort led to poor underwriting results. Kingstone is now reporting solid results, but its new expansion effort poses the same execution risks, the analyst tells investors in a research note. Piper feels the company is now better equipped to grow profitably and achieve its strategic goals.
  • KIDS Piper Sandler analyst Matt O'Brien raised the firm's price target on OrthoPediatrics to $45 from $30 and keeps an Overweight rating on the shares. OrthoPediatrics is at the start of a multi-year new product cycle which the firm expects to drive meaningful upside to current consensus estimates over the next few years. Across the portfolio, Piper has identified more than a dozen new products which will help OrthoPediatrics access the $2.8B global TAM much more effectively.
  • PANW Piper Sandler raised the firm's price target on Palo Alto Networks to $450 from $410 and keeps an Overweight rating on the shares. The firm notes the company delivered impressive Q1 results, highlighted by acceleration across all three product segments and the largest revenue beat in over five years. The elevated pace of vulnerability discovery is driving more customers to consolidate spend as many rush to patch and protect against the AI-driven attack landscape. The company also announced the $4.5B acquisition of Applied Compute, deepening its ability to build specialized cyber models and help enterprises safely deploy open-weight models. Overall, Q1 results gave Piper incremental confidence in the accelerated pace of consolidation in security and Palo Alto's ability to capitalize on this.
  • AMGN Piper Sandler raised the firm's price target on Amgen to $542 from $457 and keeps an Overweight rating on the shares. The firm's post-Q3 model now reflects contribution from dazodalibep in Sjogren's disease patients with moderate-to-severe systemic disease burden, as well as contribution from Imdelltra as maintenance therapy in first-line extensive-stage small cell lung cancer. Piper believes both opportunities alone support further value creation, and beyond that, it thinks that the depth of pipeline/label expansion opportunities behind the two aforementioned products supports further multiple expansion from a current EV/2027 EBITDA of about 15-times, particularly in the context of a base business that should continue to generate the kind of growth that can overcome future loss of exclusivity exposure.

ROSENBLATT

  • PANW Rosenblatt raised the firm's price target on Palo Alto Networks to $460 from $415 and keeps a Buy rating on the shares. The company beat every sales and earnings guided metric in fiscal Q1 and materially raised its fiscal 2027 outlook, the analyst tells investors in a research note. The firm views Palo Alto's quarter as a "clean beat."
  • UTI Rosenblatt lowered the firm's price target on Universal Technical to $35 from $45 and keeps a Buy rating on the shares. Guidance for FY27 "disappointed," says the analyst, who is trimming the firm's FY27 revenue view by 4.5% and adjusted EBITDA forecast by 13%.

STIFEL

  • BRBR Stifel analyst Matthew Smith raised the firm's price target on BellRing Brands to $18 from $15 and keeps a Buy rating on the shares. BellRing reported "a strong fourth quarter," says the analyst, who is raising the firm's EBITDA estimate to incorporate a stronger gross margin performance.
  • TGT Stifel raised the firm's price target on Target to $160 from $155 and keeps a Hold rating on the shares. The firm raised its sales and EPS estimates to reflect the traffic driven comp beat, November sales pickup and possibility of further tariff refund realization, but given the lackluster consumer backdrop and moderation forecast by its model, Stifel believes "the market will need to be patient."

SUSQUEHANNA

  • BILL Susquehanna downgraded Bill to Neutral from Positive with an unchanged price target of $73. The company's "remarkable" financial and operational turnaround has driven meaningful shareholder returns, the analyst tells investors in a research note. Reports of takeover interest has moved the shares towards the price target, adds the firm. Susquehanna says that with a prospective buyout bid in play, "events now drive the stock." It sees "modest upside" potential from current levels with downside of a failed takeover process. As such, Bill's risk/reward no longer supports a Positive rating, contends Susquehanna.

TD COWEN

  • BILL TD Cowen analyst Jared Levine raised the firm's price target on Bill to $76 from $66 and keeps a Buy rating on the shares after hosting meetings with management. Bill's improving sales productivity supports the implied growth uptick in the second half of the fiscal year, the analyst tells investors in a research note. TD also believes the company's margins have additional runway for expansion post fiscal 2027.
  • BRBR TD Cowen raised the firm's price target on BellRing Brands to $15 from $9 and keeps a Hold rating on the shares. The firm updated its model following the new announced strategy for improving operational effectiveness and early signs of stabilizing sales.

UBS

  • UNM UBS analyst Michael Ward upgraded Unum Group to Buy from Neutral with a price target of $111, up from $94. The firm believes the market is underappreciating Unum's 8% potential upside to 2027 consensus earnings estimates from improving mortality. At the same time, the company's risk transfer has significantly reduced long-term care risk, with 70% of the block now in the lower-risk group category, the analyst tells investors in a research note. UBS sees earnings beats driven by improving mortality and lower risk of long-term care reserve charges as catalysts for the shares.
  • RGA UBS upgraded Reinsurance Group to Buy from Neutral with a price target of $325, up from $236. The market is overlooking Reinsurance's upside from continued mortality improvements and from Equitable deal accretion, the analyst tells investors in a research note. The firm believes the company's setup combines "earnings upside with defensive characteristics" given that Reinsurance has no equity market exposure and limited macro sensitivity.
  • WWD UBS raised the firm's price target on Woodward to $467 from $455 and keeps a Buy rating on the shares. Woodward's Aerospace and Industrial businesses continue to deliver strong growth, with LEAP/GTF aftermarket ramps and double-digit Industrial growth supporting upside potential, while capacity investments weigh on near-term cash flow but position the company for long-term outperformance, the analyst tells investors in a research note.
  • PANW UBS raised the firm's price target on Palo Alto Networks to $400 from $390 and keeps a Neutral rating on the shares. Palo Alto Networks delivered broad-based strength with net new annual recurring revenue $180M above guidance, accelerating ARR and revenue growth for a third straight quarter, while strong Observability and product demand reinforce large platforms' ability to capture a disproportionate share of security spending, the analyst tells investors in a research note.

WELLS FARGO

  • AJG Wells Fargo downgraded Arthur J. Gallagher to Equal Weight from Overweight with a price target of $294, down from $312. The firm adjusted ratings in the insurance broker group, saying brokers remain its favored sub-sector, with WTW Wells' top idea. The firm sees see slowing brokerage organic growth for Arthur J. Gallagher.
  • AON Wells Fargo downgraded Aon plc to Equal Weight from Overweight with an unchanged price target of $364. The firm adjusted ratings in the insurance broker group, saying brokers remain its favored sub-sector, with WTW Wells' top idea. The firm expects "noise and volatility" in Aon's price performance following the close of the USI Insurance Services deal.
  • BRO Wells Fargo analyst Elyse Greenspan upgraded Brown & Brown to Overweight from Equal Weight with a price target of $82, up from $68. The firm adjusted ratings in the insurance broker group, saying brokers remain its favored sub-sector, with WTW Wells' top idea. The firm says Brown has a "low bar" for its organic growth heading into 2027, given the weakness seen over the past couple of years. Wells sees the company's growth improving to 2.6% from 0.4% next year.
  • WTW Wells Fargo raised the firm's price target on WTW to $390 from $360 and keeps an Overweight rating on the shares. The firm adjusted ratings in the insurance broker group, saying brokers remain its favored sub-sector, with WTW Wells' top idea. WTW incited a pick-up in organic in Q4 and is guiding to 30% margins in 2028 yet "remains cheapest of the group," the analyst tells investors in a research note.
  • PGR Wells Fargo analyst Elyse Greenspan lowered the firm's price target on Progressive to $194 from $196 and keeps an Underweight rating on the shares. The firm notes shares underperformed after another sequential decline in PIF in the direct channel and muted growth in total personal auto. Wells estimates personal auto PIFs to decline sequentially over remaining two months of 2026.
  • GBDC Wells Fargo analyst Finian O'Shea lowered the firm's price target on Golub Capital to $12 from $13 and keeps an Overweight rating on the shares. The firm says Golub Capital continues to show willingness to "do the right thing" for shareholders throughout its recent credit patch.
  • PANW Wells Fargo lowered the firm's price target on Palo Alto Networks to $510 from $525 and keeps an Overweight rating on the shares. Against a more favorable setup, the company delivered a strong beat and raise, led by an acceleration in "core" NGS NNARR, as AI tailwinds kicked into gear, the firm says. Wells sees drum beat getting louder in cyber, with Applied Compute adding a new dimension to story.

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

 

 

 

 

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

 

Monday November 16th

Economic Calendar: 

  • 8:30 AM ET NY Empire Manufacturing for November

Earnings Calendar:

  • Earnings Before the Open: ARMK BEKE BIDU BLDP BXDC DTST GAME HTHT IQ PERI POET TSN VENU XPEV XTNT XXII
  • Earnings After the Close: ACM AYTU BAER BRFH DARE DUOT FTLF INFQ MNTK OMER PAGS PARA POWL RCAT SHAZ STEM TMS TRAK WRAP XP YALA

Other Key Events:

  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital Markets Global Industrials Conference 11/16-11/17, in New York
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Supercomputing 2026, 11/15-11/20, in New Orleans

Tuesday November 17th

Economic Calendar: 

  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:30 AM ET                   Retail Sales M/M for October
  • 8:30 AM ET                   Retail Sales – Less Autos M/M for October
  • 8:30 AM ET                   Import Prices M/M for October
  • 8:30 AM ET                   Export Prices M/M for October
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 9:15 AM ET                   Industrial Production M/M for October
  • 9:15 AM ET                   Capacity utilization for October
  • 10:00 AM ET                 Business Inventory M/M for September
  • 10:00 AM ET NAHB Housing Market Index for November
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AS DIS ENR ESLT FUBO GFF HD HUYA JD KLAR LUXE MNSO ONEW OPRA SMWB SR TME VIK WB
  • Earnings After the Close: DLB GBDC GLAD IIIV IRIX LZB NVDA SQM WAST ZTO

Other Key Events:

  • Citizens Financial Services Conference, 11/17, in New York
  • Deutsche Bank Residential REIT summit (virtual), 11/17
  • Deutsche Bank 5th Annual Global Space Summit, 11/17-11/18, in New York
  • Jefferies 5th Miami Consumer Conference, 11/17-11/18, in Miami, FL
  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital Markets Global Industrials Conference 11/16-11/17, in New York
  • RBC Capital 2026 Global TIMT Conference, 11/17-11/18, in New York
  • Rosenblatt Silicon Valley field trip, 11/17-11/18
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Roth Capital 15th Annual Technology Conference, 11/17-11/18, in New York
  • Supercomputing 2026, 11/15-11/20, in New Orleans
  • TD Cowen 2026 Financials & Fintech Conference, 11/17-11/18, in New York

Wednesday November 18th

Economic Calendar: 

  • 7:00 AM ET MBA Mortgage Applications Data
  • 8:30 AM ET                   Housing Starts M/M for October
  • 8:30 AM ET                   Building Permits M/M for October
  • 10:00 AM ET                 Pending Home Sales M/M for October
  • 10:30 AM ET                 Weekly EIA Inventory Data
  • 1:00 PM ET US Treasury to sell $13B in 20-year notes
  • 4:00 PM ET                    Net Long-term TIC Flows for September

Earnings Calendar:

  • Earnings Before the Open: BLSH BRBR CSHR GLBE GLNG JJSF JMIA KRNT LOW PONY PRE TCEHY TGT TJX ZIM ZKH
  • Earnings After the Close: CPA HP JOYY KLIC NJR P PANW PCYO RRGB SBLK UGI UTI WWD

Other Key Events:

  • Deutsche Bank 5th Annual Global Space Summit, 11/17-11/18, in New York
  • Jefferies 5th Miami Consumer Conference, 11/17-11/18, in Miami, FL
  • Piper Sandler Financial Services Conference, 11/16-11/18, in Miami, FL
  • RBC Capital 2026 Global TIMT Conference, 11/17-11/18, in New York
  • Rosenblatt Silicon Valley field trip, 11/17-11/18
  • Roth Capital 13th Annual Solar & Storage Symposium at RE +, 11/16-11/18, Las Vegas
  • Roth Capital 15th Annual Technology Conference, 11/17-11/18, in New York
  • Supercomputing 2026, 11/15-11/20, in New Orleans
  • TD Cowen 2026 Financials & Fintech Conference, 11/17-11/18, in New York

Thursday November 19th

Economic Calendar: 

  • 8:30 AM ET                   Weekly Jobless Claims
  • 8:30 AM ET                   Continuing Claims
  • 8:30 AM ET                   Philly Fed Business Index for November
  • 10:00 AM ET                 Leading Index M/M for October
  • 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data
  • 11:00 AM ET                 Kansas City Fed Manufacturing for November

Earnings Calendar:

  • Earnings Before the Open: ARBE BABA BBWI DAO EVGN FUTU LQDT MANU MMS NTES RERE ROAD TEN VVV WMG WMT YMM
  • Earnings After the Close: BULL CLIR EARN ESE ESTC GAP GLOB INTU KEYS MATW NGVC POST ROST

Other Key Events:

  • Deutsche Bank Gaming, Lodging, Leisure One on One Conference 11/19-11/20, in Miami, FL
  • Supercomputing 2026, 11/15-11/20, in New Orleans

Friday November 20th

Economic Calendar: 

  • 10:00 AM ET                 University of Michigan Confidence, Nov-Final
  • 10:00 AM ET                 University of Michigan 1-yr and 5-yr inflation expectation, Nov -Final
  • 1:00 PM ET                    Baker Hughes Weekly rig count data

Earnings Calendar:

  • Earnings Before the Open: BJ BKE BSP FRO RLX WRD

Other Key Events:

  • Deutsche Bank Gaming, Lodging, Leisure One on One Conference 11/19-11/20, in Miami, FL
  • Supercomputing 2026, 11/15-11/20, in New Orleans

 

 

.

As a value-added service exclusive to Regal Securities account holders, The Hammerstone Report is available to read daily on the trading platform.

Hammerstone Inc. (the “Report”) provides information and data and does NOT provide any individual investment advice or money management assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity.

Content is provided for educational and informational purposes only and Regal Securities cannot attest to its accuracy or completeness. No information provided has been endorsed by Regal Securities and does not constitute a recommendation by Regal Securities to buy or sell a particular investment. You are solely responsible for your own investment decisions and Regal Securities makes no investment recommendations and does not provide financial, tax, or legal advice. Regal Securities may provide links to internet sites maintained by third parties. Unless expressly stated otherwise, links in these reports are not sponsored by nor are they the responsibility of Regal Securities. Regal Securities has not verified the content, accuracy, or opinions expressed on any links in these reports and disclaims any warranty or liability for damages associated therewith.

Copyright 2006-2026 Regal Securities, Inc., Member FINRA/SIPC | Important Disclosures

Your privacy is important to us; see our Privacy Policy for details.

Regal Securities, 950 Milwaukee Ave., Ste. 102, Glenview, IL 60025
Website: www.regalsecurities.com | Toll-free: 1-877-488-6534
Representatives are available Monday through Friday from 8:00 a.m. to 5:00 p.m. EST.